Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
28 hedge funds and large institutions have $10.5M invested in Axcella Health Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 29 → 28 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
56% less capital invested
Capital invested by funds: $23.6M → $10.5M (-$13.1M)
89% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$9.42K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$216 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$285K |
| 2 |
CCM
CAAS Capital Management
New York
|
-$54.3K |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$50K |
| 4 |
BlackRock
New York
|
-$19.3K |
| 5 |
Millennium Management
New York
|
-$17.7K |
AXLA Hedge Fund Activity: Q2 2023 in Review
28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2023, worth a combined $10.5M — down 56% from $23.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AXLA and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $9.42K. The largest seller was Fidelity Investments, cutting an estimated $285K.
- 28 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2023, down from 29 in Q1 2023.
- Funds reported $10.5M of Axcella Health Inc. Common Stock stock for Q2 2023, down 56% quarter-over-quarter.
- 3 funds opened new Axcella Health Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of -1 holder.
- The largest Axcella Health Inc. Common Stock buyer in Q2 2023 was Morgan Stanley, an estimated $9.42K added.
- The largest Axcella Health Inc. Common Stock seller in Q2 2023 was Fidelity Investments, an estimated $285K sold.
Based on aggregated 13F filings for Q2 2023.